Physician

Alexandria Bass Glass, D.O.

According to 2025 Medicare claims, Alexandria Glass, D.O. (NPI: 1174916365) practices dermatology, with the plurality of this provider's patient population coming from Sampson, NC. This provider's primary affiliated billing organization is GLASS DERMATOLOGY PLLC (NPI: 1184299034; TIN: 863699557) and primary practice location at 28328-2806.

Glass' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 482 traditional Medicare patients, billed 4,784 HCPCS/CPT codes, and received $348,595 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,780 prescription claims across 582 beneficiaries totaling $829,936 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 77 records totaling $1,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $59,096 to $348,595. Similarly, Part D prescription costs have moved sharply higher in recent years, from $126 to $829,936. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$174K$349K2020 Medicare payment: $59,096 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $139,867 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $214,701 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $321,153 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $348,595 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20202261,227$59,096
20214172,420$139,867
20224133,478$214,701
20236165,732$321,153
20244824,784$348,595

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$415K$830K2015 Drug cost: $126 (USD; Tot_Drug_Cst)2016 Drug cost: $305 (USD; Tot_Drug_Cst)2021 Drug cost: $2,001 (USD; Tot_Drug_Cst)2022 Drug cost: $151,696 (USD; Tot_Drug_Cst)2023 Drug cost: $619,747 (USD; Tot_Drug_Cst)2024 Drug cost: $829,936 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R18$126
20161116$305
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213670$2,001
2022376993$151,696
20235521,629$619,747
20245821,780$829,936

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more222355$81
11102Biopsy of related skin growth, first growth168223$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more258410$58
17000Destruction of precancer skin growth, 1 growth249400$33
17003Destruction of precancer skin growth, 2-14 growths2031,509$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa161,238$329,410
Cosentyx Unoready PenSecukinumab19532$165,780
Dupixent PenDupilumab251,022$136,972
Clobetasol PropionateClobetasol Propionate2014,974$8,910
TacrolimusTacrolimus381,125$4,772

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$1,545GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandria Bass Glass, D.O.?

Tedicare shows public-source Medicare data for Alexandria Bass Glass, D.O. (NPI 1174916365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandria Bass Glass, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandria Bass Glass, D.O.?

Alexandria Bass Glass, D.O. is linked to GLASS DERMATOLOGY PLLC (billing NPI 1184299034) in the available physician profile data.

Does Alexandria Bass Glass, D.O. have Open Payments data?

Alexandria Bass Glass, D.O. has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.